Research Open Terminal →
HUM

Humana

XNYS · HOSPITAL & MEDICAL SERVICE PLANS

1 article20 insider tx20 holders0 supply chain2 selling intent filings4 new insiders

Financials

SEC XBRL company-facts figures. Quarterly and annual periods are shown separately and are not mixed with year-to-date totals. Click a figure for the filing it came from.

Latest quarter at a glance

Q3'26

Revenue

$41.2B
Exact value
$41,155,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2026-07-01 to 2026-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index

YoY 26.1%

Operating income (GAAP)

$75M
Exact value
$75,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2026-07-01 to 2026-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index

YoY -81.3%

Net income

$162Mattributable to parent
Exact value
$162,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2026-07-01 to 2026-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index

YoY -16.9%

Diluted EPS

$1.33
Exact value
$1.33 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2026-07-01 to 2026-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index

YoY -17.9%

Quarterly

Data through quarter ended September 30, 2026 · Source filing date: November 6, 2026

$0B$20B$40BQ2'24 $29,540,000,000 USD$29,540,000,000 USDQ3'24 $29,397,000,000 USD$29,397,000,000 USDQ1'25 $32,112,000,000 USD$32,112,000,000 USDQ2'25 $32,388,000,000 USD$32,388,000,000 USDQ3'25 $32,649,000,000 USD$32,649,000,000 USDQ1'26 $39,648,000,000 USD$39,648,000,000 USDQ2'26 $40,867,000,000 USD$40,867,000,000 USDQ3'26 $41,155,000,000 USD$41,155,000,000 USDQ2'24Q3'24Q1'25Q2'25Q3'25Q1'26Q2'26Q3'26
Revenue
PeriodValue
Q2'24$29,540,000,000 USD
Q3'24$29,397,000,000 USD
Q1'25$32,112,000,000 USD
Q2'25$32,388,000,000 USD
Q3'25$32,649,000,000 USD
Q1'26$39,648,000,000 USD
Q2'26$40,867,000,000 USD
Q3'26$41,155,000,000 USD

Revenue

PeriodValuePriorYoY
Q3'26 · quarter ended 2026-09-30
$41.2B
Exact value
$41,155,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2026-07-01 to 2026-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index
$32.6B26.1%
Q2'26 · quarter ended 2026-06-30
$40.9B
Exact value
$40,867,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2026-04-01 to 2026-06-30
Accession
0000049071-26-000050
Form
10-Q
Filed
2026-07-29
Derivation
direct
Filing
SEC filing index
$32.4B26.2%
Q1'26 · quarter ended 2026-03-31
$39.6B
Exact value
$39,648,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2026-01-01 to 2026-03-31
Accession
0000049071-26-000023
Form
10-Q
Filed
2026-04-29
Derivation
direct
Filing
SEC filing index
$32.1B23.5%
Q3'25 · quarter ended 2025-09-30
$32.6B
Exact value
$32,649,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2025-07-01 to 2025-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000057 10-Q filed 2025-11-05
$29.4B11.1%
Q2'25 · quarter ended 2025-06-30
$32.4B
Exact value
$32,388,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2025-04-01 to 2025-06-30
Accession
0000049071-26-000050
Form
10-Q
Filed
2026-07-29
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000042 10-Q filed 2025-07-30
$29.5B9.6%
Q1'25 · quarter ended 2025-03-31
$32.1B
Exact value
$32,112,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2025-01-01 to 2025-03-31
Accession
0000049071-26-000023
Form
10-Q
Filed
2026-04-29
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000023 10-Q filed 2025-04-30
$29.6B8.4%
Q3'24 · quarter ended 2024-09-30
$29.4B
Exact value
$29,397,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2024-07-01 to 2024-09-30
Accession
0000049071-25-000057
Form
10-Q
Filed
2025-11-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000055 10-Q filed 2024-10-30
$26.4B11.3%
Q2'24 · quarter ended 2024-06-30
$29.5B
Exact value
$29,540,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2024-04-01 to 2024-06-30
Accession
0000049071-25-000042
Form
10-Q
Filed
2025-07-30
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000040 10-Q filed 2024-07-31
$26.7B10.4%

Operating income (GAAP)

PeriodValuePriorYoY
Q3'26 · quarter ended 2026-09-30
$75M
Exact value
$75,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2026-07-01 to 2026-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index
$400M-81.3%
Q2'26 · quarter ended 2026-06-30
$1.4B
Exact value
$1,360,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2026-04-01 to 2026-06-30
Accession
0000049071-26-000050
Form
10-Q
Filed
2026-07-29
Derivation
direct
Filing
SEC filing index
$1.1B23.9%
Q1'26 · quarter ended 2026-03-31
$1.8B
Exact value
$1,754,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2026-01-01 to 2026-03-31
Accession
0000049071-26-000023
Form
10-Q
Filed
2026-04-29
Derivation
direct
Filing
SEC filing index
$2B-12.9%
Q3'25 · quarter ended 2025-09-30
$400M
Exact value
$400,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2025-07-01 to 2025-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000057 10-Q filed 2025-11-05
$728M-45.1%
Q2'25 · quarter ended 2025-06-30
$1.1B
Exact value
$1,098,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2025-04-01 to 2025-06-30
Accession
0000049071-26-000050
Form
10-Q
Filed
2026-07-29
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000042 10-Q filed 2025-07-30
$1.1B-3.8%
Q1'25 · quarter ended 2025-03-31
$2B
Exact value
$2,014,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2025-01-01 to 2025-03-31
Accession
0000049071-26-000023
Form
10-Q
Filed
2026-04-29
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000023 10-Q filed 2025-04-30
$1.2B62.9%
Q3'24 · quarter ended 2024-09-30
$728M
Exact value
$728,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2024-07-01 to 2024-09-30
Accession
0000049071-25-000057
Form
10-Q
Filed
2025-11-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000055 10-Q filed 2024-10-30
$1.2B-39.6%
Q2'24 · quarter ended 2024-06-30
$1.1B
Exact value
$1,141,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2024-04-01 to 2024-06-30
Accession
0000049071-25-000042
Form
10-Q
Filed
2025-07-30
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000040 10-Q filed 2024-07-31
$1.4B-20.5%

Net income

PeriodValuePriorYoY
Q3'26 · quarter ended 2026-09-30
$162Mattributable to parent
Exact value
$162,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2026-07-01 to 2026-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index
$195M-16.9%
Q2'26 · quarter ended 2026-06-30
$694Mattributable to parent
Exact value
$694,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2026-04-01 to 2026-06-30
Accession
0000049071-26-000050
Form
10-Q
Filed
2026-07-29
Derivation
direct
Filing
SEC filing index
$545M27.3%
Q1'26 · quarter ended 2026-03-31
$1.2Battributable to parent
Exact value
$1,186,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2026-01-01 to 2026-03-31
Accession
0000049071-26-000023
Form
10-Q
Filed
2026-04-29
Derivation
direct
Filing
SEC filing index
$1.2B-4.7%
Q3'25 · quarter ended 2025-09-30
$195Mattributable to parent
Exact value
$195,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2025-07-01 to 2025-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000057 10-Q filed 2025-11-05
$480M-59.4%
Q2'25 · quarter ended 2025-06-30
$545Mattributable to parent
Exact value
$545,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2025-04-01 to 2025-06-30
Accession
0000049071-26-000050
Form
10-Q
Filed
2026-07-29
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000042 10-Q filed 2025-07-30
$679M-19.7%
Q1'25 · quarter ended 2025-03-31
$1.2Battributable to parent
Exact value
$1,244,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2025-01-01 to 2025-03-31
Accession
0000049071-26-000023
Form
10-Q
Filed
2026-04-29
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000023 10-Q filed 2025-04-30
$741M67.9%
Q3'24 · quarter ended 2024-09-30
$480Mattributable to parent
Exact value
$480,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2024-07-01 to 2024-09-30
Accession
0000049071-25-000057
Form
10-Q
Filed
2025-11-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000055 10-Q filed 2024-10-30
$832M-42.3%
Q2'24 · quarter ended 2024-06-30
$679Mattributable to parent
Exact value
$679,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2024-04-01 to 2024-06-30
Accession
0000049071-25-000042
Form
10-Q
Filed
2025-07-30
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000040 10-Q filed 2024-07-31
$959M-29.2%

Diluted EPS

PeriodValuePriorYoY
Q3'26 · quarter ended 2026-09-30
$1.33
Exact value
$1.33 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2026-07-01 to 2026-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index
$1.62-17.9%
Q2'26 · quarter ended 2026-06-30
$5.73
Exact value
$5.73 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2026-04-01 to 2026-06-30
Accession
0000049071-26-000050
Form
10-Q
Filed
2026-07-29
Derivation
direct
Filing
SEC filing index
$4.5127.1%
Q1'26 · quarter ended 2026-03-31
$9.83
Exact value
$9.83 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2026-01-01 to 2026-03-31
Accession
0000049071-26-000023
Form
10-Q
Filed
2026-04-29
Derivation
direct
Filing
SEC filing index
$10.30-4.6%
Q3'25 · quarter ended 2025-09-30
$1.62
Exact value
$1.62 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2025-07-01 to 2025-09-30
Accession
0000049071-26-000066
Form
10-Q
Filed
2026-11-06
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000057 10-Q filed 2025-11-05
$3.98-59.3%
Q2'25 · quarter ended 2025-06-30
$4.51
Exact value
$4.51 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2025-04-01 to 2025-06-30
Accession
0000049071-26-000050
Form
10-Q
Filed
2026-07-29
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000042 10-Q filed 2025-07-30
$5.62-19.8%
Q1'25 · quarter ended 2025-03-31
$10.30
Exact value
$10.30 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2025-01-01 to 2025-03-31
Accession
0000049071-26-000023
Form
10-Q
Filed
2026-04-29
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000023 10-Q filed 2025-04-30
$6.1168.6%
Q3'24 · quarter ended 2024-09-30
$3.98
Exact value
$3.98 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2024-07-01 to 2024-09-30
Accession
0000049071-25-000057
Form
10-Q
Filed
2025-11-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000055 10-Q filed 2024-10-30
$6.71-40.7%
Q2'24 · quarter ended 2024-06-30
$5.62
Exact value
$5.62 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2024-04-01 to 2024-06-30
Accession
0000049071-25-000042
Form
10-Q
Filed
2025-07-30
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000040 10-Q filed 2024-07-31
$7.66-26.6%

Annual

Data through fiscal year ended December 31, 2025 · Source filing date: February 19, 2026

$0B$50B$100B2020-12-31 $77,155,000,000 USD$77,155,000,000 USDFY21 $83,064,000,000 USD$83,064,000,000 USDFY22 $92,870,000,000 USD$92,870,000,000 USDFY23 $106,374,000,000 USD$106,374,000,000 USDFY24 $117,761,000,000 USD$117,761,000,000 USDFY25 $129,664,000,000 USD$129,664,000,000 USD2020-12-31FY21FY22FY23FY24FY25
Revenue
PeriodValue
2020-12-31$77,155,000,000 USD
FY21$83,064,000,000 USD
FY22$92,870,000,000 USD
FY23$106,374,000,000 USD
FY24$117,761,000,000 USD
FY25$129,664,000,000 USD

Revenue

PeriodValuePriorYoY
FY25 · year ended 2025-12-31
$129.7B
Exact value
$129,664,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2025-01-01 to 2025-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index
$117.8B10.1%
FY24 · year ended 2024-12-31
$117.8B
Exact value
$117,761,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2024-01-01 to 2024-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000007 10-K filed 2025-02-20
$106.4B10.7%
FY23 · year ended 2023-12-31
$106.4B
Exact value
$106,374,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2023-01-01 to 2023-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000012 10-K filed 2024-02-15
  • 0000049071-25-000007 10-K filed 2025-02-20
$92.9B14.5%
FY22 · year ended 2022-12-31
$92.9B
Exact value
$92,870,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2022-01-01 to 2022-12-31
Accession
0000049071-25-000007
Form
10-K
Filed
2025-02-20
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-23-000011 10-K filed 2023-02-16
  • 0000049071-24-000012 10-K filed 2024-02-15
$83.1B11.8%
FY21 · year ended 2021-12-31
$83.1B
Exact value
$83,064,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2021-01-01 to 2021-12-31
Accession
0000049071-24-000012
Form
10-K
Filed
2024-02-15
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-22-000017 10-K filed 2022-02-17
  • 0000049071-23-000011 10-K filed 2023-02-16
$77.2B7.7%
year ended 2020-12-31
$77.2B
Exact value
$77,155,000,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
Revenues
Also reported
RevenueFromContractWithCustomerIncludingAssessedTax
Period
2020-01-01 to 2020-12-31
Accession
0000049071-23-000011
Form
10-K
Filed
2023-02-16
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-21-000039 10-K filed 2021-02-18
  • 0000049071-22-000017 10-K filed 2022-02-17
——

Operating income (GAAP)

PeriodValuePriorYoY
FY25 · year ended 2025-12-31
$2.7B
Exact value
$2,704,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2025-01-01 to 2025-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index
$2.6B5.5%
FY24 · year ended 2024-12-31
$2.6B
Exact value
$2,562,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2024-01-01 to 2024-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000007 10-K filed 2025-02-20
$4B-36.2%
FY23 · year ended 2023-12-31
$4B
Exact value
$4,013,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2023-01-01 to 2023-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000007 10-K filed 2025-02-20
  • 0000049071-24-000012 10-K filed 2024-02-15
$3.8B5.6%
FY22 · year ended 2022-12-31
$3.8B
Exact value
$3,800,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2022-01-01 to 2022-12-31
Accession
0000049071-25-000007
Form
10-K
Filed
2025-02-20
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000012 10-K filed 2024-02-15
  • 0000049071-23-000011 10-K filed 2023-02-16
$3.1B20.7%
FY21 · year ended 2021-12-31
$3.1B
Exact value
$3,148,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2021-01-01 to 2021-12-31
Accession
0000049071-24-000012
Form
10-K
Filed
2024-02-15
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-23-000011 10-K filed 2023-02-16
  • 0000049071-22-000017 10-K filed 2022-02-17
$5B-36.9%
year ended 2020-12-31
$5B
Exact value
$4,986,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2020-01-01 to 2020-12-31
Accession
0000049071-23-000011
Form
10-K
Filed
2023-02-16
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-22-000017 10-K filed 2022-02-17
  • 0000049071-21-000039 10-K filed 2021-02-18
——

Net income

PeriodValuePriorYoY
FY25 · year ended 2025-12-31
$1.2Battributable to parent
Exact value
$1,188,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2025-01-01 to 2025-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index
$1.2B-1.6%
FY24 · year ended 2024-12-31
$1.2Battributable to parent
Exact value
$1,207,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2024-01-01 to 2024-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000007 10-K filed 2025-02-20
$2.5B-51.5%
FY23 · year ended 2023-12-31
$2.5Battributable to parent
Exact value
$2,489,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2023-01-01 to 2023-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000007 10-K filed 2025-02-20
  • 0000049071-24-000012 10-K filed 2024-02-15
$2.8B-11.3%
FY22 · year ended 2022-12-31
$2.8Battributable to parent
Exact value
$2,806,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2022-01-01 to 2022-12-31
Accession
0000049071-25-000007
Form
10-K
Filed
2025-02-20
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000012 10-K filed 2024-02-15
  • 0000049071-23-000011 10-K filed 2023-02-16
$2.9B-4.3%
FY21 · year ended 2021-12-31
$2.9Battributable to parent
Exact value
$2,933,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2021-01-01 to 2021-12-31
Accession
0000049071-24-000012
Form
10-K
Filed
2024-02-15
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-23-000011 10-K filed 2023-02-16
  • 0000049071-22-000017 10-K filed 2022-02-17
$3.4B-12.9%
year ended 2020-12-31
$3.4Battributable to parent
Exact value
$3,367,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2020-01-01 to 2020-12-31
Accession
0000049071-23-000011
Form
10-K
Filed
2023-02-16
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-22-000017 10-K filed 2022-02-17
  • 0000049071-21-000039 10-K filed 2021-02-18
——

Diluted EPS

PeriodValuePriorYoY
FY25 · year ended 2025-12-31
$9.84
Exact value
$9.84 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2025-01-01 to 2025-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index
$9.98-1.4%
FY24 · year ended 2024-12-31
$9.98
Exact value
$9.98 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2024-01-01 to 2024-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000007 10-K filed 2025-02-20
$20.00-50.1%
FY23 · year ended 2023-12-31
$20.00
Exact value
$20.00 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2023-01-01 to 2023-12-31
Accession
0000049071-26-000009
Form
10-K
Filed
2026-02-19
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-25-000007 10-K filed 2025-02-20
  • 0000049071-24-000012 10-K filed 2024-02-15
$22.08-9.4%
FY22 · year ended 2022-12-31
$22.08
Exact value
$22.08 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2022-01-01 to 2022-12-31
Accession
0000049071-25-000007
Form
10-K
Filed
2025-02-20
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-24-000012 10-K filed 2024-02-15
  • 0000049071-23-000011 10-K filed 2023-02-16
$22.67-2.6%
FY21 · year ended 2021-12-31
$22.67
Exact value
$22.67 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2021-01-01 to 2021-12-31
Accession
0000049071-24-000012
Form
10-K
Filed
2024-02-15
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-23-000011 10-K filed 2023-02-16
  • 0000049071-22-000017 10-K filed 2022-02-17
$25.31-10.4%
year ended 2020-12-31
$25.31
Exact value
$25.31 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2020-01-01 to 2020-12-31
Accession
0000049071-23-000011
Form
10-K
Filed
2023-02-16
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000049071-22-000017 10-K filed 2022-02-17
  • 0000049071-21-000039 10-K filed 2021-02-18
——

Research articles

Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.

View all articles →

Recent insider activity

Insider net $ (monthly)open-market Form 4 only - grants, exercises, tax withholding excluded$5.0M$2.5M$0-$2.5M-$5.0M2024-10 $02024-11 $02024-12 -$949K2025-01 $02025-02 $02025-03 $02025-04 $02025-05 $1.5M2025-06 $02025-07 $02025-08 $02025-09 $02025-10 $02025-11 $02025-12 $02026-01 $02026-02 $150K2026-03 $02026-04 $02026-05 $02026-06 $02026-07 $02026-08 $02026-09 $02026-10 $02026-11 -$2.6MInstitutional shares (majority-gated quarters)50.0M25.0M02025-Q4 45.3M sh2026-Q1 30.1M sh2026-Q2 30.7M shOct 24Dec 24Feb 25Apr 25Jun 25Aug 25Oct 25Dec 25Feb 26Apr 26Jun 26Aug 26Oct 26Q4 2025Q1 2026Q2 2026~ derived from SEC-reported shares x price. Hatched: excluded (implausible price) or unpriced.

open-market Form 4 only - grants, exercises, tax withholding excluded

0 buyers - 2 unique sellers · 7 accumulating - 3 trimming - 2 unchanged

Date Insider Title Type Shares Price Value
November 10, 2026 Dintenfass David President, Enterprise Growth GIFT -230 — —
November 10, 2026 Frederick Wayne A.I. — SELL -440 $441 ~$0.2M
November 9, 2026 Ventura Joseph C Chief Legal Officer GIFT -437 — —
November 9, 2026 Ventura Joseph C Chief Legal Officer SELL -5,495 $434 ~$2.4M
September 30, 2026 Hilzinger Kurt J — GRANT 238 $385 ~$92K
September 1, 2026 Nundy Shantanu Chief Medical Officer GRANT 2,549 — —
August 1, 2026 Smith Paul John — GRANT 544 — —
August 1, 2026 Crawford Frederick John — GRANT 544 — —
June 30, 2026 Hilzinger Kurt J — GRANT 233 $392 ~$91K
May 1, 2026 Mellet Celeste Chief Financial Officer GRANT -15,387 — —
May 1, 2026 Mehta Japan Chief Information Officer GRANT 9,448 — —
May 1, 2026 Dintenfass David President, Enterprise Growth GRANT 11,273 — —
May 1, 2026 Rechtin James A. President & CEO GRANT 35,633 — —
May 1, 2026 O'Hara Michelle A. Chief Human Resources Officer GRANT 10,485 — —
May 1, 2026 Field Robert Stuart — GRANT 852 — —
May 1, 2026 Ventura Joseph C Chief Legal Officer GRANT 10,318 — —
May 1, 2026 Shetty Sanjay K President, CenterWell GRANT 9,945 — —
May 1, 2026 Martin Aaron President, Medicare Advantage GRANT 8,206 — —
April 1, 2026 Shetty Sanjay K President, CenterWell OPTION_EXERCISE 887 — —
April 1, 2026 Shetty Sanjay K President, CenterWell TAX_WITHHOLD -401 $175 ~$70K

Insider Selling Intent (Form 144)

Date Filer Relationship Est. shares Filing
November 10, 2026 Frederick Wayne A.I. — 440 SEC
November 9, 2026 Ventura Joseph C — 5,495 SEC

New Insiders (Form 3)

Date Insider Title Relationship Shares Filing
August 31, 2026 — — — — SEC
July 29, 2026 — — — — SEC
July 29, 2026 — — — — SEC
April 21, 2026 — — — — SEC

Institutional holdings

Institution Shares Value ($) Change % Filing date
BlackRock 11,108,587 ~$4.2B prior history unverified August 13, 2024
BlackRock 10,417,803 ~$4.1B 2.1% August 7, 2026
Vanguard Group 14,261,860 ~$3.7B prior history unverified January 29, 2026
BlackRock 10,632,797 ~$2.7B prior history unverified February 12, 2026
State Street 5,457,072 ~$2.2B 0.1% August 7, 2026
BlackRock 10,199,055 ~$1.8B -4.1% May 13, 2026
JP Morgan Chase 4,087,837 ~$1.6B -1.0% August 12, 2026
State Street 5,462,549 ~$1.4B prior history unverified February 13, 2026
JP Morgan Chase 5,344,531 ~$1.4B prior history unverified February 11, 2026
Goldman Sachs 3,144,289 ~$1.2B 10.0% August 14, 2026
Fidelity (FMR) 2,913,763 ~$1.2B 2.8% August 13, 2026
State Street 5,452,992 ~$950.2M -0.2% May 15, 2026
Citadel Advisors 2,146,522 ~$852.6M 19.0% August 14, 2026
Fidelity (FMR) 3,215,616 ~$823.6M prior history unverified February 17, 2026
JP Morgan Chase 4,127,428 ~$685.2M -22.8% May 13, 2026
Morgan Stanley 1,349,066 ~$535.9M -6.8% August 13, 2026
Goldman Sachs 2,859,494 ~$495.8M 82.5% May 15, 2026
Fidelity (FMR) 2,834,302 ~$491.4M -11.9% May 15, 2026
Citadel Advisors 1,698,451 ~$435.0M prior history unverified February 17, 2026
Goldman Sachs 1,567,205 ~$401.4M prior history unverified March 25, 2026
Want deeper analysis?
Investabot monitors SEC filings daily and generates institutional-grade research on insider trades, risk factors, supply chains, and more.
Open the Terminal — Free →